Literature DB >> 22672922

Considerations in developing and delivering a nonpharmacological intervention for symptom management in lung cancer: the views of patients and informal caregivers.

Jackie Ellis1, Richard Wagland, Carol Tishelman, Mari Lloyd Williams, Chris D Bailey, Jemma Haines, Ann Caress, Paul Lorigan, Jaclyn A Smith, Richard Booton, Fiona Blackhall, Alexander Molassiotis.   

Abstract

CONTEXT: Few studies consider patient's and caregiver's preferences when developing nonpharmacological interventions. This is important to develop acceptable and accessible nonpharmacological interventions for patients with cancer.
OBJECTIVES: The objective of this study was to identify the views of patients with lung cancer and their informal caregivers on the desirable components of a novel nonpharmacological intervention for the management of the symptom cluster of cough, breathlessness, and fatigue, and their needs and preferences regarding uptake and delivery of the intervention.
METHODS: This study was qualitative in orientation, using semistructured interviews and framework analysis to elicit the views of 37 patients with lung cancer and 23 caregivers regarding the issues that were perceived to be important regarding the development and delivery of a nonpharmacological intervention.
RESULTS: A number of key issues were identified that carried important implications for patient participation and adherence to the intervention, including the perceived relevance of potential techniques; appreciable benefits in the short term; convenience; variation in patient preferences; timing of the intervention; venue; caregiver involvement; the provider of the intervention, and contact with other patients.
CONCLUSION: The data from this study have provided insight into the key issues that are likely to influence the development, uptake, and delivery of a nonpharmacological intervention to help manage the respiratory symptom cluster of cough, breathlessness, and fatigue. It is crucial that these findings are considered when developing and modeling a nonpharmacological symptom management intervention.
Copyright © 2012 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22672922     DOI: 10.1016/j.jpainsymman.2011.12.274

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  15 in total

1.  Development of a Symptom Management Intervention: Qualitative Feedback From Advanced Lung Cancer Patients and Their Family Caregivers.

Authors:  Catherine E Mosher; Mary A Ott; Nasser Hanna; Shadia I Jalal; Victoria L Champion
Journal:  Cancer Nurs       Date:  2017 Jan/Feb       Impact factor: 2.592

Review 2.  Involvement of patients with lung and gynecological cancer and their relatives in psychosocial cancer rehabilitation: a narrative review.

Authors:  Bente Hoeck; Loni Ledderer; Helle Ploug Hansen
Journal:  Patient       Date:  2015-04       Impact factor: 3.883

Review 3.  Understanding factors influencing physical activity and exercise in lung cancer: a systematic review.

Authors:  Catherine L Granger; Bronwen Connolly; Linda Denehy; Nicholas Hart; Phillip Antippa; Kuan-Yin Lin; Selina M Parry
Journal:  Support Care Cancer       Date:  2016-11-29       Impact factor: 3.603

Review 4.  Cancer Symptom Cluster Management.

Authors:  Kristine L Kwekkeboom
Journal:  Semin Oncol Nurs       Date:  2016-10-24       Impact factor: 2.315

Review 5.  Patient-centred clinical trial design.

Authors:  Allison Tong; Nicole Scholes-Robertson; Carmel Hawley; Andrea K Viecelli; Simon A Carter; Adeera Levin; Brenda R Hemmelgarn; Tess Harris; Jonathan C Craig
Journal:  Nat Rev Nephrol       Date:  2022-06-06       Impact factor: 42.439

6.  Outcome of supportive talks in a hospital setting: insights from cancer patients and their relatives.

Authors:  Loni Ledderer; Karen la Cour; Helle Ploug Hansen
Journal:  Patient       Date:  2014       Impact factor: 3.883

7.  Management of the respiratory distress symptom cluster in lung cancer: a randomised controlled feasibility trial.

Authors:  Janelle Yorke; Mari Lloyd-Williams; Jacky Smith; Fiona Blackhall; Amelie Harle; June Warden; Jackie Ellis; Mark Pilling; Jemma Haines; Karen Luker; Alex Molassiotis
Journal:  Support Care Cancer       Date:  2015-06-26       Impact factor: 3.603

8.  Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial.

Authors:  Morag C Farquhar; A Toby Prevost; Paul McCrone; Barbara Brafman-Price; Allison Bentley; Irene J Higginson; Chris Todd; Sara Booth
Journal:  BMC Med       Date:  2014-10-31       Impact factor: 8.775

9.  Considerations in developing and delivering a non-pharmacological intervention for symptom management in lung cancer: the views of health care professionals.

Authors:  Richard Wagland; Jackie Ellis; Chris D Bailey; Jemma Haines; Ann Caress; Mari Lloyd Williams; Paul Lorigan; Jaclyn Smith; Carol Tishelman; Richard Booton; Karen Luker; Fiona Blackhall; Alex Molassiotis
Journal:  Support Care Cancer       Date:  2012-01-20       Impact factor: 3.603

10.  Using the framework method for the analysis of qualitative data in multi-disciplinary health research.

Authors:  Nicola K Gale; Gemma Heath; Elaine Cameron; Sabina Rashid; Sabi Redwood
Journal:  BMC Med Res Methodol       Date:  2013-09-18       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.